Categories: World

UPDATE 3-Novartis beats forecasts with $6 billion profit as it navigates expiring patents

(Adds analyst comments throughout, adds shares in paragraph 2) * Entresto sales fall 50% as US generic competition intensifies * Novartis maintains full-year operating profit outlook * Shares…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: July 21, 2026 13:23:10 IST

(Adds analyst comments throughout, adds shares in paragraph 2) * Entresto sales fall 50% as US generic competition intensifies * Novartis maintains full-year operating profit outlook * Shares rise 2%

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: July 21, 2026 13:23:10 IST

Recent Posts

ANALYSIS-Trump's diesel price relief efforts grow costlier as election nears

* $8 billion farm aid pushes payments to a record $55.4 billion * Analysts see…

October 23, 2026

Meta to delay new commercial terms criticised by publishers, advertisers

By Foo Yun Chee BRUSSELS, Oct 23 (Reuters) - Meta Platforms will delay the implementation…

October 23, 2026

Exclusive-Fast-fashion group Shein agrees to pay $100 million to settle US FTC probe

By Helen Reid and Jody Godoy LONDON, Oct 23 (Reuters) - Chinese fast-fashion giant Shein…

October 23, 2026